Talphera (TLPH)

• Market cap: $57.3M
• 1 day: -4.65%
• 5 days: -3.15%
• 1 month: -3.15%
• 3 months: 44.2%
• 6 months: 138.79%
• Year to date: 108.44%
• 1 year: 64%
• 5 years: -95.58%
• 10 years: -98.7%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13